These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

153 related items for PubMed ID: 10329616

  • 1. Haploid loss of bax leads to accelerated mammary tumor development in C3(1)/SV40-TAg transgenic mice: reduction in protective apoptotic response at the preneoplastic stage.
    Shibata MA, Liu ML, Knudson MC, Shibata E, Yoshidome K, Bandey T, Korsmeyer SJ, Green JE.
    EMBO J; 1999 May 17; 18(10):2692-701. PubMed ID: 10329616
    [Abstract] [Full Text] [Related]

  • 2. Expression of a viral oncoprotein during mammary gland development alters cell fate and function: induction of p53-independent apoptosis is followed by impaired milk protein production in surviving cells.
    Li M, Hu J, Heermeier K, Hennighausen L, Furth PA.
    Cell Growth Differ; 1996 Jan 17; 7(1):3-11. PubMed ID: 8788028
    [Abstract] [Full Text] [Related]

  • 3. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis.
    Li M, Lewis B, Capuco AV, Laucirica R, Furth PA.
    Oncogene; 2000 Feb 21; 19(8):1010-9. PubMed ID: 10713684
    [Abstract] [Full Text] [Related]

  • 4. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice.
    Liu ML, Shibata MA, Von Lintig FC, Wang W, Cassenaer S, Boss GR, Green JE.
    Oncogene; 2001 Apr 12; 20(16):2044-9. PubMed ID: 11360188
    [Abstract] [Full Text] [Related]

  • 5. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE, Shibata MA, Shibata E, Moon RC, Anver MR, Kelloff G, Lubet R.
    Cancer Res; 2001 Oct 15; 61(20):7449-55. PubMed ID: 11606379
    [Abstract] [Full Text] [Related]

  • 6. Bax accelerates tumorigenesis in p53-deficient mice.
    Knudson CM, Johnson GM, Lin Y, Korsmeyer SJ.
    Cancer Res; 2001 Jan 15; 61(2):659-65. PubMed ID: 11212265
    [Abstract] [Full Text] [Related]

  • 7. p53-independent apoptosis during mammary tumor progression in C3(1)/SV40 large T antigen transgenic mice: suppression of apoptosis during the transition from preneoplasia to carcinoma.
    Shibata MA, Maroulakou IG, Jorcyk CL, Gold LG, Ward JM, Green JE.
    Cancer Res; 1996 Jul 01; 56(13):2998-3003. PubMed ID: 8674054
    [Abstract] [Full Text] [Related]

  • 8. Overexpression of aromatase leads to hyperplasia and changes in the expression of genes involved in apoptosis, cell cycle, growth, and tumor suppressor functions in the mammary glands of transgenic mice.
    Kirma N, Gill K, Mandava U, Tekmal RR.
    Cancer Res; 2001 Mar 01; 61(5):1910-8. PubMed ID: 11280746
    [Abstract] [Full Text] [Related]

  • 9. Lymphoma development in Bax transgenic mice is inhibited by Bcl-2 and associated with chromosomal instability.
    Luke JJ, Van De Wetering CI, Knudson CM.
    Cell Death Differ; 2003 Jun 01; 10(6):740-8. PubMed ID: 12761582
    [Abstract] [Full Text] [Related]

  • 10. Bax suppresses tumorigenesis and stimulates apoptosis in vivo.
    Yin C, Knudson CM, Korsmeyer SJ, Van Dyke T.
    Nature; 1997 Feb 13; 385(6617):637-40. PubMed ID: 9024662
    [Abstract] [Full Text] [Related]

  • 11. Apoptosis and remodeling of mammary gland tissue during involution proceeds through p53-independent pathways.
    Li M, Hu J, Heermeier K, Hennighausen L, Furth PA.
    Cell Growth Differ; 1996 Jan 13; 7(1):13-20. PubMed ID: 8788029
    [Abstract] [Full Text] [Related]

  • 12. p53 mutations and p53, Waf-1, Bax and Bcl-2 expression in field cancerization of the head and neck.
    Lavieille JP, Gazzeri S, Riva C, Reyt E, Brambilla C, Brambilla E.
    Anticancer Res; 1998 Jan 13; 18(6B):4741-9. PubMed ID: 9891551
    [Abstract] [Full Text] [Related]

  • 13. Human prolactin and its antagonist, hPRL-G129R, regulate bax and bcl-2 gene expression in human breast cancer cells and transgenic mice.
    Peirce SK, Chen WY.
    Oncogene; 2004 Feb 12; 23(6):1248-55. PubMed ID: 14647416
    [Abstract] [Full Text] [Related]

  • 14. Dietary lutein inhibits mouse mammary tumor growth by regulating angiogenesis and apoptosis.
    Chew BP, Brown CM, Park JS, Mixter PF.
    Anticancer Res; 2003 Feb 12; 23(4):3333-9. PubMed ID: 12926072
    [Abstract] [Full Text] [Related]

  • 15. Immunofluorometric study of Bcl-2 and Bax expression in clinical fresh tumor samples from breast cancer patients.
    Martínez-Arribas F, Núñez-Villar MJ, Lucas AR, Sánchez J, Tejerina A, Schneider J.
    Anticancer Res; 2003 Feb 12; 23(1B):565-8. PubMed ID: 12680147
    [Abstract] [Full Text] [Related]

  • 16. SV40 T/t-antigen induces premature mammary gland involution by apoptosis and selects for p53 missense mutation in mammary tumors.
    Tzeng YJ, Zimmermann C, Guhl E, Berg B, Avantaggiati ML, Graessmann A.
    Oncogene; 1998 Apr 23; 16(16):2103-14. PubMed ID: 9572491
    [Abstract] [Full Text] [Related]

  • 17. Bcl-2 and Bax are differentially expressed in hyperplastic, premalignant, and malignant lesions of mammary carcinogenesis.
    Shilkaitis A, Graves J, Mehta RR, Hu L, You M, Lubet R, Steele V, Kelloff G, Christov K.
    Cell Growth Differ; 2000 Aug 23; 11(8):437-45. PubMed ID: 10965848
    [Abstract] [Full Text] [Related]

  • 18. Estrogen promotes mammary tumor development in C3(1)/SV40 large T-antigen transgenic mice: paradoxical loss of estrogen receptoralpha expression during tumor progression.
    Yoshidome K, Shibata MA, Couldrey C, Korach KS, Green JE.
    Cancer Res; 2000 Dec 15; 60(24):6901-10. PubMed ID: 11156389
    [Abstract] [Full Text] [Related]

  • 19. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI, Calvo A, Stafford J, Cheung M, Kumar R, Philp D, Kleinman HK, Green JE.
    Oncogene; 2005 Jan 27; 24(5):790-800. PubMed ID: 15592523
    [Abstract] [Full Text] [Related]

  • 20. Absence of p53 in a mouse mammary tumor model promotes tumor cell proliferation without affecting apoptosis.
    Jones JM, Attardi L, Godley LA, Laucirica R, Medina D, Jacks T, Varmus HE, Donehower LA.
    Cell Growth Differ; 1997 Aug 27; 8(8):829-38. PubMed ID: 9269892
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.